Most scaling SMEs do not have a reporting problem, they have a decision problem. The board pack arrives on time, the numbers reconcile, and yet the MD still cannot tell whether cash is tightening, margin is slipping, or a customer issue is turning into a working capital headache. That is
A finance lead often spots the same pattern. The business has spent heavily on product development, process changes, software improvement, or production problem-solving, yet nobody is fully sure whether that work counts for R&D Tax Relief. That uncertainty matters because this isn't just a tax compliance issue. It affects cash
Has academic research ever made a UK founder more money? Most leaders of businesses turning over £1 million to £15 million would probably say no. They'd be forgiven for thinking management accounting research belongs in universities, not in board packs, pricing reviews, or monthly cash meetings. That view costs money.
A founder has built a solid company, the management team is capable, and stepping back is starting to feel realistic. The problem is that an external sale may feel disruptive, uncertain, or misaligned with what the owner wants for the business. That's usually when the question lands on the table.
